Effects of hormonal treatment on the female reproductive system
Ovaries
Two groups of sex hormones are produced in the ovaries: oestrogen and progesterone. These are steroid hormones that contribute to the development and function of the female reproductive organs and sex characteristics. At the onset of puberty, oestrogen promotes:
- Breast development
- Distribution of fat in the hips, legs, and breasts
- Maturation of reproductive organs such as the uterus and vagina
Progesterone causes the lining of the uterus to thicken in preparation for pregnancy. Together, progesterone and oestrogen are responsible for the changes that occur in the uterus during the menstrual cycle.
Hormone treatments are often used to treat breast cancer and sometimes uterine cancer. Treatments include anti oestrogen drugs, progesterone and aromatase inhibitors some of which are listed here:
- Anastrozole (Arimidex®)
- Exemestane (Aromasin®)
- Goserelin (Zoladex®)
- Letrozole (Femara®)
- Medroxyprogesterone acetate (Provera® Depo-Provera® Farlutal®)
- Megestrol acetate (Megace®)
- Tamoxifen
- Toremifene (Fareston®)
Although a women’s fertility is not directly affected by a loss of sexual desire there may be an indirect effect due to hormonal treatments causing a reduced libido.
The ovaries can be affected by hormonal treatments such as those used in breast cancer. Endocrine therapy can slow or stop the growth of breast cancer cells either by altering the levels of particular hormones which are naturally produced in the body, or preventing the hormones from being taken up by the cancer cells.(42) As a result fertility may be affected, although it may return when the hormonal treatment has stopped (if the woman is still premenopausal).
Although hormonal treatments can affect fertility (sometimes only temporarily) it is important that contraception is used as pregnancy can still occur during this time and the effects upon the foetus are unknown.